Identification of genes that predict the response to chemotherapy with 5-azacytidine in myelodysplastic syndromes

被引：0
|
作者：
Matsumoto, Taichi [1 ,2 ]
Murakami, Yuichi [1 ]
Katsuchi, Daisuke [1 ]
Kuwano, Michihiko [1 ]
Ono, Mayumi [1 ,3 ]
机构：
[1] St Marys Inst Hlth Sci, Canc Transl Res Ctr, Fukuoka, Japan
[2] Fukuoka Univ, Dept Drug Inform, Pharm Sci, Fukuoka, Japan
[3] St Marys Coll, Grad Sch Nursing, Dept Pharm Oncol, Fukuoka, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2366
引用
收藏
页码：1261 / 1261
页数：1
相关论文
共 50 条
  • [1] 5-Azacytidine for the treatment of myelodysplastic syndromes
    Krawczyk, Janusz
    Keane, Niamh
    Freeman, Ciara Louise
    Swords, Ronan
    O'Dwyer, Michael
    Giles, Francis J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (09) : 1255 - 1268
  • [2] Treatment of myelodysplastic syndromes with 5-azacytidine
    Gryn, J
    Zeigler, ZR
    Shadduck, RK
    Lister, J
    Raymond, JM
    Sbeitan, I
    Srodes, C
    Meisner, D
    Evans, C
    LEUKEMIA RESEARCH, 2002, 26 (10) : 893 - 897
  • [3] 5-Azacytidine in myelodysplastic syndromes: A clinical practice guideline
    Buckstein, Rena
    Yee, Karen
    Wells, Richard A.
    CANCER TREATMENT REVIEWS, 2011, 37 (02) : 160 - 167
  • [4] TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) WITH SUBCUTANEOUS 5-AZACYTIDINE (AZA C)
    RUGO, H
    DAMON, L
    RIES, C
    LINKER, C
    BLOOD, 1994, 84 (10) : A317 - A317
  • [5] Prognostic Impact of the Number of Methylated Genes in Myelodysplastic Syndromes and Acute Myeloid Leukemias Treated with 5-Azacytidine
    Abaigar, Maria
    Ramos, Fernando
    Benito, Rocio
    Diez-Campelo, Maria
    Sanchez-del-Real, Javier
    Hermosin, Lourdes
    Rodriguez, Juan N.
    Aguilar, Carlos
    Recio, Isabel
    Alonso, Jose M.
    de-las-Heras, Natalia
    Megido, Marta
    Fuertes, Marta
    Canizo, Consuelo
    Hernandez, Jesus M.
    San Miguel, Jesus F.
    BLOOD, 2012, 120 (21)
  • [6] Myelodysplastic Syndromes/Myeloproliferative Neoplasms Treated with 5-Azacytidine. Results from the Hellenic 5-Azacytidine Registry
    Diamantopoulos, Panagiotis Theodorou
    Kotsianidis, Ioannis
    Symeonidis, Argiris
    Pappa, Vassiliki
    Galanopoulos, Athanasios
    Gogos, Dimitrios
    Roussou, Paraskevi
    Papadaki, Helen A.
    Palla, Aikaterini
    Hatzimichael, Eleftheria
    Dimou, Maria
    Delibasi, Sossana
    Papoutselis, Menelaos Konstantinos
    Kourakli, Alexandra
    Tsokanas, Dimitrios
    Rougala, Niki
    Panayiotidis, Panayiotis
    Viniou, Nora-Athina
    BLOOD, 2017, 130
  • [7] EFFECTS OF TREATMENT WITH 5-AZACYTIDINE ON THE INVIVO AND INVITRO HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    SILVERMAN, LR
    HOLLAND, JF
    WEINBERG, RS
    ALTER, BP
    DAVIS, RB
    ELLISON, RR
    DEMAKOS, EP
    CORNELL, CJ
    CAREY, RW
    SCHIFFER, C
    ILL, EF
    MCINTYRE, OR
    LEUKEMIA, 1993, 7 : 21 - 29
  • [8] Response of autoimmune and inflammatory disorders in myelodysplastic syndromes to 5-azacytidine: report of two cases and literature review
    Wu, Dan-Yang
    Wang, Jing
    Zhang, Rui
    Yan, Xiao-Jing
    Gao, Ran
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (08) : 9276 - 9280
  • [9] Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia
    Raza, Azral
    Mehdi, Munaza
    Mumtaz, Muhammad
    Ali, Fahad
    Lascher, Steven
    Galili, Naomi
    CANCER, 2008, 113 (07) : 1596 - 1604
  • [10] RAPID HAEMATOLOGICAL RESPONSE WITH 5-AZACYTIDINE IN HIGH RISK MYELODYSPLASTIC SYNDROME
    Roy, J.
    Weston-Smith, S.
    Sahu, S.
    Grace, R.
    Dimitriadou, E.
    Nikolova, A.
    Rumbold, A.
    Gupta, S.
    HAEMATOLOGICA, 2013, 98 : 590 - 590
12345